Stonepine Capital Management, LLC Applied Genetic Technologies Corp Transaction History

Stonepine Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.01 - $4.12 $3,010 - $4,120	-1,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.62 - $5.23 $646,209 - $933,612	-178,511 Reduced 99.44%	1,000 $4,000
Q1 2021 May 14, 2021	BUY	$3.94 - $8.19 $707,273 - $1.47 Million	179,511 New	179,511 $910,000
Q2 2020 Aug 13, 2020	SELL	$3.0 - $6.9 $1.76 Million - $4.05 Million	-586,969 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$2.36 - $9.86 $1.39 Million - $5.79 Million	586,969 New	586,969 $1.93 Million

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.